On August 18, 2020, the U.S. Patent Office published a guidance memorandum regarding the treatment of applicant statements in a patent challenged in an IPR (“applicant admitted prior art” or “AAPA”). The PTO observed that different Board panels had reached inconsistent interpretations as to whether and how 35 U.S.C. § 311(b) limits an IPR petitioner’s reliance on those statements.
